Key Research Statistics
Anxiolytic & Cognitive Enhancement
92.8%Intranasal BioavailabilityNear-complete nasal absorption — no injection required
0Dependence RiskNo sedation, amnesia, tolerance, or withdrawal — unlike benzodiazepines
Hamilton Anxiety Scale (Human Study)
2700 µg/day intranasal — rapid vs conventional responders
Baseline20.3
Rapid (Day 3)7
Conventional (Day 14)6.2
Koroleva 2019 (n=20)
Anxiolytic Effect — Benzodiazepine Comparison
Comparable efficacy, no dependence risk
Selank — No Dependence90
Medazepam — Addictive95
Frontiers in Pharmacology 2016
Selank at the Cellular Level
Anxiolytic neuropeptide

Selank in the Body
Synthetic tuftsin analog with anxiolytic properties

Complete Your Protocol
Complementary compounds from other research areas






